HEMOPHILIA FEDERATION OF AMERICA for HEMOPHILIA FEDERATION AMERICA
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 1600 The Patients' Access to Treatment Act - states that an insurance company cannot charge more for drug placed on specialty tier than drug placed in non-preferred brand tier; HR 2624 the Part D Beneficiaries Appeals Act creates an appeals process in Medicare Part D for drugs that are placed on Specialty Tiers; potential legislation regarding access for those with hemophilia to skilled nursing facilities; raised awareness regarding CMS rule that is allowing insurance companies to deny third party nonprofits to pay premiums for those with chronic and rare disorders
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATIE VERB | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.